Edition:
United States

Idorsia Ltd (IDIA.S)

IDIA.S on Swiss Exchange

26.40CHF
16 Feb 2018
Change (% chg)

CHF0.14 (+0.53%)
Prev Close
CHF26.26
Open
CHF26.68
Day's High
CHF26.68
Day's Low
CHF26.10
Volume
331,634
Avg. Vol
490,504
52-wk High
CHF30.70
52-wk Low
CHF10.00

Select another date:

Tue, Feb 6 2018

BRIEF-Idorsia FY US GAAP Loss Of CHF 8 Million

* US GAAP OPERATING RESULTS 2017: YTD LOSS OF CHF 8 MILLION; Q4 PROFIT OF CHF 71 MILLION

Idorsia to get $230 million from J&J in latest hypertension deal

ZURICH Idorsia , the Swiss drugmaker spun off from Actelion after it was bought by Johnson & Johnson (J&J) , will receive a one-time payment of $230 million from J&J's Janssen unit as they partner on aprocitentan for resistant hypertension.

Idorsia to get $230 mln from J&J in latest hypertension deal

ZURICH, Dec 4 Idorsia, the Swiss drugmaker spun off from Actelion after it was bought by Johnson & Johnson (J&J), will receive a one-time payment of $230 million from J&J's Janssen unit as they partner on aprocitentan for resistant hypertension.

BRIEF-Idorsia Announces Collaboration With Janssen Biotech On Aprocitentan

* IDORSIA ANNOUNCES COLLABORATION WITH JANSSEN BIOTECH ON APROCITENTAN (ACT-132577)

Select another date: